| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Revenue | $805.9M | -3.6% |
| Cost of Revenue | $553.6M | -3.5% |
| Gross Profit | $252.3M | -3.6% |
| R&D Expense | $20.1M | +4.7% |
| SG&A Expense | $139.0M | -6.6% |
| Operating Income | $81.8M | +2.4% |
| Pre-tax Income | $50.5M | +2.6% |
| Income Tax | $11.5M | -1.7% |
| Net Income | $39.0M |
| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $44.1M | +36.1% |
| Accounts Receivable | $104.6M | -8.9% |
| Inventory | $190.1M | -11.6% |
| Current Assets | $384.2M | -3.2% |
| Total Assets | $1.51B | -5.3% |
| Current Liabilities | $138.6M | -4.3% |
| Long-term Debt | $450.6M | -14.2% |
| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | $122.1M | +45.5% |
| Capital Expenditures | $27.0M | -21.3% |
| Investing Cash Flow | -$30.3M | +80.3% |
| Financing Cash Flow | -$78.4M | -235.4% |
| Free Cash Flow | $95.1M | +91.7% |
| +4.0% |
| EPS (Basic) | $1.17 | +2.6% |
| EPS (Diluted) | $1.17 | +2.6% |
| Total Liabilities |
| $641.0M |
| -12.9% |
| Stockholders' Equity | $864.4M | +1.1% |